Literature DB >> 32188390

The Interaction of GLUT1 and FOXM1 Leads to a Poor Prognosis in Colorectal Cancer.

Xiao-Yi Kuai1, Zhi-Yi Lei2, Xiao-Shuang Liu3, Xin-Yu Shao1.   

Abstract

BACKGROUND: Colorectal Cancer (CRC) is one of the most common fatal diseases with high morbidity. Alteration of glucose metabolism is one of the hallmarks in the development of CRC. Glucose Transporter 1 (GLUT1) is a key rate-limiting protein in hyperactive glucose metabolism and up-regulated in CRC, however, the underlying mechanism of the altered metabolism in CRC is still unknown.
METHODS: In this study, immunohistochemical staining was used to evaluate the expression of GLUT1 and FOXM1 in 135 paired CRC and adjacent normal tissues. The association between the expression of GLUT1/FOXM1 and clinicopathological factors was determined and the correlation between GLUT1 and FOXM1 in CRC was investigated.
RESULTS: Our results revealed that regardless of tumor location, GLUT1 and FOXM1 were overexpressed in CRC tissues, especially in patients with positive lymph node metastasis and TNM stage III-IV. Furthermore, GLUT1 showed a significantly strong link with FOXM1 in CRC tissue.
CONCLUSION: Overexpression of GLUT1 and FOXM1 may play critical roles in CRC leading to a poor prognosis. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Colorectal cancer; FOXM1; GLUT1; altered metabolism; immunohistochemical staining; prognosis

Mesh:

Substances:

Year:  2020        PMID: 32188390     DOI: 10.2174/1871520620666200318094618

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  1 in total

1.  β-Boswellic Acid Suppresses Breast Precancerous Lesions via GLUT1 Targeting-Mediated Glycolysis Inhibition and AMPK Pathway Activation.

Authors:  Fengjie Bie; Guijuan Zhang; Xianxin Yan; Xinyi Ma; Sha Zhan; Yebei Qiu; Jingyu Cao; Yi Ma; Min Ma
Journal:  Front Oncol       Date:  2022-05-31       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.